Disease staging and sub setting of interstitial lung disease associated with systemic sclerosis: impact on therapy

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

(2017) Dimitrios Daoussis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

(2017) Elizabeth R. Volkmann et al.   Arthritis & Rheumatology

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

(2017) Nicole S. Goh et al.   Arthritis & Rheumatology

Pneumonia intersticial associada à esclerose sistêmica: avaliação da função pulmonar no período de cinco anos

(2017) Agnaldo José Lopes et al.   Jornal Brasileiro de Pneumologia

Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis

(2016) Anne-Marie Russell et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment

(2016) Hyun J Kim et al.   ANNALS OF THE RHEUMATIC DISEASES

Utility of FVC/DLCO ratio to stratify the risk of mortality in unselected subjects with pulmonary hypertension

(2016) Lacedonia Donato et al.   Internal and Emergency Medicine

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

(2016) D. Khanna et al.   JOURNAL OF RHEUMATOLOGY

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension

(2016) K. M. Antoniou et al.   Arthritis & Rheumatology

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

(2016) Donald P Tashkin et al.   Lancet Respiratory Medicine

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

(2015) R Gisli Jenkins et al.   Lancet Respiratory Medicine

Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease

(2014) Tiffany A. Winstone et al.   CHEST

Interstitial lung disease in connective tissue disease—mechanisms and management

(2014) Athol U. Wells et al.   Nature Reviews Rheumatology

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?

(2013) Ulf Müller-Ladner et al.   ANNALS OF THE RHEUMATIC DISEASES

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

(2013) J Gerry Coghlan et al.   ANNALS OF THE RHEUMATIC DISEASES

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

(2013) Lenny van Bon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of systemic sclerosis

(2012) Jammie Barnes et al.   CURRENT OPINION IN RHEUMATOLOGY

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

(2012) O. A. Moore et al.   RHEUMATOLOGY

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

(2011) Roland M. du Bois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease

(2011) Michael D. Roth et al.   ARTHRITIS AND RHEUMATISM

Clinical Characteristics and Survival in Systemic Sclerosis-Related Pulmonary Hypertension Associated With Interstitial Lung Disease

(2011) David Launay et al.   CHEST

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Cyclophosphamide for scleroderma lung disease: a systematic review and meta-analysis

(2011) Hadi Poormoghim et al.   RHEUMATOLOGY INTERNATIONAL

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

(2010) A. J. Tyndall et al.   ANNALS OF THE RHEUMATIC DISEASES

Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease

(2010) Maria De Santis et al.   Clinical Respiratory Journal

Anti-U11/U12 RNP antibodies in systemic sclerosis: A new serologic marker associated with pulmonary fibrosis

(2009) Noreen Fertig et al.   ARTHRITIS AND RHEUMATISM

Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma

(2009) F. N. HANT et al.   JOURNAL OF RHEUMATOLOGY

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

(2009) Dimitrios Daoussis et al.   RHEUMATOLOGY

Interstitial Lung Disease in Systemic Sclerosis

(2008) Nicole S. L. Goh et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High-resolution computed tomography and scleroderma lung disease

(2008) A. U. Wells   RHEUMATOLOGY

Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada

(2008) Firas F. Al-Dhaher et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies

(2008) Carlotta Nannini et al.   ARTHRITIS RESEARCH & THERAPY

Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease

(2007) Charlie Strange et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review

(2007) Hélène Chifflot et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM